HOME >> MEDICINE >> NEWS
Fred Hutchinson oversees two grants of nearly $8 million to develop blood test for breast cancer

The Fred Hutchinson Cancer Research Center will oversee two major grants totaling nearly $8 million to develop a blood test that can be used in conjunction with mammography to improve early detection of breast cancer.

The first, a $7 million, four-year Breast Cancer Center of Excellence grant to Fred Hutchinson from the U.S. Department of Defense, will involve investigators from 10 institutions in Seattle, Houston and Los Angeles. (Please see list.)

The second is a grant of nearly $1 million from a unique, multi-year, public-private partnership of the Avon Foundation and the National Cancer Institute called "Progress for Patients." The funds will be split equally among Fred Hutchinson, the University of Alabama, Fox Chase Cancer Center and M.D. Anderson Cancer Center. (Please see sidebar for more details about the Avon/NCI grant.)

Nicole Urban, Sc.D., a member of Fred Hutchinson's Public Health Sciences Division, will serve as principal investigator of both initiatives.

"Our goal for both projects is to evaluate a variety of breast-cancer biomarkers for their contribution to the early detection of breast cancer. Our vision is that a simple blood test could be used along with mammography to detect breast cancer early in the disease process. We are particularly interested in markers that identify aggressive forms of breast cancer that are missed by mammography," said Urban, also a research professor of health services in the UW School of Public Health and Community Medicine.

While mammography indeed saves lives - reducing deaths from breast cancer by up to 30 percent among women over age 50 - it misses about one in five breast cancers overall. Mammography is least effective in detecting cancer in younger women, who tend to have dense breast tissue that is difficult to X-ray. Other limitations of mammography in younger women include a high rate of false positives that result in unnecessary biopsies and the inability to distinguish between aggre
'"/>

Contact: Kristen Woodward
kwoodwar@fhcrc.org
206-667-5095
Fred Hutchinson Cancer Research Center
3-Oct-2002


Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Fred Hutchinson receives $9.7 million to lead early detection consortium
2. Fred Hutchinson uses IBM technology to help find genetic links to immune-system diseases
3. Fred Hutchinson Cancer Research Center study shows retinoids kill childhood brain tumor cells
4. Fred Hutchinson Research Center awarded $7 million grant
5. Fred Hutchinson receives $12.7 million to lead prostate-cancer consortium
6. Hutchinson Center receives $1.2 million from National Science Foundation to study plant genetics
7. Of vasectomies, vitamins and prostate-cancer risk: Hutchinson Center study examines the links
8. Fred Hutchinson Cancer Research Center And Targeted Genetics Corp. Publish Data On Adoptive Immunotherapy For HIV
9. UNH launches 2nd spinout company with NIH grants
10. Disease testing for immigrants: Discrimination disguised as public health policy
11. US FDA grants full approval to DOXIL(R) following submission of phase III data

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/24/2017)... ... April 24, 2017 , ... The world-class designers of ... bring their novel lifesaving device for the everyday use of parents worldwide. It ... designed to read a child’s vital signs, and detect unusual symptoms or physical ...
(Date:4/24/2017)... NEW PORT RICHEY, Fla. (PRWEB) , ... April ... ... Disease Control and Prevention (CDC), rising prescription opioid overdose deaths now claim the ... (DEA) has slashed its civil case filings against drug manufacturers, distributors, pharmacies and ...
(Date:4/24/2017)... ... April 24, 2017 , ... Pitavastatin, a relatively new ... is not known to have significant interactions with antiretroviral therapy (ART). Among ... levels and dampen inflammation in the bloodstream. , While lowering cholesterol and dampening ...
(Date:4/24/2017)... KNOLLS, Calif. (PRWEB) , ... April 24, 2017 , ... ... health topics, but she has not found any of them to be very practical. ... actions to slowly and easily make changes in their health. It prompted her in ...
(Date:4/24/2017)... ... , ... “The Saint with Trin, and Omega Station”: a triple feature offering ... of published author, Chris Jackson. Chris Jackson grew up in Abilene, Texas. ... School District teaching English. He is heavily involved in the youth group of his ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... The Mobile X-Ray product segment is the most ... the forecast period Mobile X-Ray segment is the ... X-Ray devices market, which is estimated to be valued at ... CAGR of 7% over the forecast period. Mobile X-Ray segment ... US$ 100 Mn in 2017 over 2016. The segment,s revenue ...
(Date:4/19/2017)... YORK , April 19, 2017 ... This report on the prostate cancer therapeutics ... the global market. Increasing prevalence of prostate cancer, ... innovation in the development of new drugs & ... prostate cancer drug due to lesser side effects ...
(Date:4/19/2017)... , April 19, 2017  Sorrento Therapeutics, ... antibody-centric, clinical-stage biopharmaceutical company developing new treatments for ... the closing of its previously announced underwritten public ... at a public offering price of $2.00 per ... estimated offering expenses payable by Sorrento.  The net ...
Breaking Medicine Technology:
Cached News: